@article{JTD16754,
author = {Stephane Noble and Marco Roffi},
title = {Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue?},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {11},
year = {2017},
keywords = {},
abstract = {Since the 1980s, the mortality from myocardial infarction (MI) has regressed by approximately 25% in Western countries, not only due to the development of routine defibrillation, monitored units and early coronary reperfusion but also to the introduction of antiplatelet therapies, angiotensin-converting enzyme (ACE) inhibitors/ angiotensin-receptor blockers (ARBs), statins and betablockers.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/16754}
}